For groups receiving doxorubicin, the drug was administered intraperitoneally at a dose of 15 mg/kg body weight
Oxidation products represent another significant impurity class
The FDA-approved prescribing information does not list protein supplements as incompatible with the medication, and no pharmacokinetic interactions between tirzepatide and dietary protein have been documented
With all the buzz around these medications, it's natural to ask: who is eligible for GLP-1 medications, and could you be a candidate
Subsequently, MK-801 can attenuate neuronal excitability, and due to its conjunction with the GLP-1 receptor agonist, this effect is confined to neurons expressing the GLP-1 receptor
The rate of osteoporosis, a disease where the bones become fragile and brittle, was 3.2% in the group not taking the drug, compared to 4.1% in the GLP-1-taking group